Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuichi Sakamoto

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Cancer Science|February 3, 2015
New metastatic model of human small-cell lung cancer by orthotopic transplantation in miceShuichi Sakamoto, Hiroyuki Inoue, Shunichi Ohba, et al.
Atherosclerosis|February 8, 2005
Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteriesRenzo Y Loyaga-Rendon, Shuichi Sakamoto, Masashi Beppu, et al.
International Journal of Audiology|February 15, 2021
Loudness functions for patients with functional hearing lossSaori Shiraki, Takeshi Sato, Ryoukichi Ikeda, et al.
Plos One|February 1, 2017
Effects of Visual Speech on Early Auditory Evoked Fields - From the Viewpoint of Individual VarianceIzumi Yahata, Tetsuaki Kawase, Akitake Kanno, et al.
Frontiers in Psychology|August 7, 2023
Diversity of aphantasia revealed by multiple assessments of visual imagery, multisensory imagery, and cognitive styleJunichi Takahashi, Godai Saito, Kazufumi Omura, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
(+/-)-2-(3-Piperidyl)-1,2,3,4-tetrahydroisoquinolines as a new class of specific bradycardic agentsHideki Kubota, Akio Kakefuda, Toshihiro Watanabe, et al.
Journal of Medicinal Chemistry|October 17, 2003
Synthesis and pharmacological evaluation of 1-oxo-2-(3-piperidyl)-1,2,3,4- tetrahydroisoquinolines and related analogues as a new class of specific bradycardic agents possessing I(f) channel inhibitory activityHideki Kubota, Akio Kakefuda, Toshihiro Watanabe, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Synthesis and pharmacological evaluation of piperidinoalkanoyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agentsHideki Kubota, Toshihiro Watanabe, Akio Kakefuda, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 24, 2004
Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate-induced seizures in ratsHiroshi Yamashita, Kazushige Ohno, Yoko Amada, et al.
Chemical & Pharmaceutical Bulletin|July 2, 2019
Synthesis and Pharmacological Evaluation of 3-[(4-Oxo-4H-pyrido[3,2-e][1,3]thiazin-2-yl)(phenyl)amino]propanenitrile Derivatives as Orally Active AMPA Receptor AntagonistsHiroshi Inami, Jun-Ichi Shishikura, Tomoyuki Yasunaga, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Cancer Science|February 3, 2015
New metastatic model of human small-cell lung cancer by orthotopic transplantation in miceShuichi Sakamoto, Hiroyuki Inoue, Shunichi Ohba, et al.
Atherosclerosis|February 8, 2005
Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteriesRenzo Y Loyaga-Rendon, Shuichi Sakamoto, Masashi Beppu, et al.
International Journal of Audiology|February 15, 2021
Loudness functions for patients with functional hearing lossSaori Shiraki, Takeshi Sato, Ryoukichi Ikeda, et al.
Plos One|February 1, 2017
Effects of Visual Speech on Early Auditory Evoked Fields - From the Viewpoint of Individual VarianceIzumi Yahata, Tetsuaki Kawase, Akitake Kanno, et al.
Frontiers in Psychology|August 7, 2023
Diversity of aphantasia revealed by multiple assessments of visual imagery, multisensory imagery, and cognitive styleJunichi Takahashi, Godai Saito, Kazufumi Omura, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
(+/-)-2-(3-Piperidyl)-1,2,3,4-tetrahydroisoquinolines as a new class of specific bradycardic agentsHideki Kubota, Akio Kakefuda, Toshihiro Watanabe, et al.
Journal of Medicinal Chemistry|October 17, 2003
Synthesis and pharmacological evaluation of 1-oxo-2-(3-piperidyl)-1,2,3,4- tetrahydroisoquinolines and related analogues as a new class of specific bradycardic agents possessing I(f) channel inhibitory activityHideki Kubota, Akio Kakefuda, Toshihiro Watanabe, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Synthesis and pharmacological evaluation of piperidinoalkanoyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agentsHideki Kubota, Toshihiro Watanabe, Akio Kakefuda, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 24, 2004
Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate-induced seizures in ratsHiroshi Yamashita, Kazushige Ohno, Yoko Amada, et al.
Chemical & Pharmaceutical Bulletin|July 2, 2019
Synthesis and Pharmacological Evaluation of 3-[(4-Oxo-4H-pyrido[3,2-e][1,3]thiazin-2-yl)(phenyl)amino]propanenitrile Derivatives as Orally Active AMPA Receptor AntagonistsHiroshi Inami, Jun-Ichi Shishikura, Tomoyuki Yasunaga, et al.
Pageof 12